Effects of roscovitine, a cell cycling-dependent kinase inhibitor, on intraocular pressure of rabbit and retinal ganglion cell damage

Neuroscience Letters

Volumn 535, Issue 1, 2013, Pages 95-99

  Kasai, Hiroyoshi ^a,b   Imamura, Tomoyo ^a   Tsuruma, Kazuhiro ^a   Takahashi, Yuji ^b   Kurasawa, Takashi ^b   Hirata, Haruhisa ^b   Shimazawa, Masamitsu ^a   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b Wakamoto Pharmaceutical Co Ltd   (Japan)

Author keywords

Cyclin dependent kinase; Glaucoma; Intraocular pressure; Retinal cell death

Indexed keywords

CYCLIN DEPENDENT KINASE; ROSCOVITINE; TUNICAMYCIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME INHIBITION; EXPERIMENTAL RABBIT; GLAUCOMA; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; ISOMER; MALE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL;

ADMINISTRATION, TOPICAL; ANIMALS; CELL DEATH; CELL HYPOXIA; CELL LINE; CYCLIN-DEPENDENT KINASES; ENDOPLASMIC RETICULUM STRESS; GLUCOSE; INTRAOCULAR PRESSURE; MALE; NEUROPROTECTIVE AGENTS; PURINES; RABBITS; RETINAL GANGLION CELLS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84873259705     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.12.025     Document Type: Article

References (30)

1. Bach S., Knockaert M., Reinhardt J., Lozach O., Schmitt S., Baratte B., Koken M., Coburn S.P., Tang L., Jiang T., Liang D.C., Galons H., Dierick J.F., Pinna L.A., Meggio F., Totzke F., Schächtele C., Lerman A.S., Carnero A., Wan Y., Gray N., Meijer L. Roscovitine targets, protein kinases and pyridoxal kinase. Journal of Biological Chemistry 2005, 280:31208-31219.
2. Byrnes K.R., Faden A.I. Role of cell cycle proteins in CNS injury. Neurochemical Research 2007, 32:1799-1807.
3. Chae H.D., Kim B.M., Yun U.J., Shin D.Y. Deregulation of Cdk2 causes Bim-mediated apoptosis in p53-deficient tumors following actin damage. Oncogene 2008, 27:4115-4121.
4. Chauhan B.C., Mikelberg F.S., Balaszi A.G., LeBlanc R.P., Lesk M.R., Trope G.E. Canadian Glaucoma Study: 2. Risk factors for the progression of open-angle glaucoma. Archives of Ophthalmology 2008, 126:1030-1036.
5. Chen H., Zhang M.C., Zhang H.X. Effects of small interfering RNA approach to silence the connective tissue growth factor gene on the expression of the protein p27. Zhonghua Yan Ke Za Zhi 2010, 46:631-634.
6. Fu W., Ma L., Chu B., Wang X., Bui M.M., Gemmer J., Altiok S., Pledger W.J. The cyclin-dependent kinase inhibitor SCH 727965 (dinacliclib) induces the apoptosis of osteosarcoma cells. Molecular Cancer Therapeutics 2011, 10:1018-1027.
7. Gordon M.O., Beiser J.A., Brandt J.D., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Kass M.A. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Archives of Ophthalmology 2002, 120:714-720. (discussion 829-830).
8. Heijl A., Leske M.C., Bengtsson B., Hyman L., Bengtsson B., Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology 2002, 120:1268-1279.
9. Hwang S.G., Song S.M., Kim J.R., Park C.S., Song W.K., Chun J.S. Regulation of type II collagen expression by cyclin-dependent kinase 6, cyclin D1, and p21 in articular chondrocytes. IUBMB Life 2007, 59:90-98.
10. Kasai H., Ishisaka M., Shirasawa M., Hara H. A three-dimensional collagen gel contraction monitoring system that uses a porcine trabecular meshwork for screening of anti-intraocular pressure agents. Pharmaceutica Analytica Acta 2012, 3:154.
11. Katchanov J., Harms C., Gertz K., Hauck L., Waeber C., Hirt L., Priller J., von Harsdorf R., Bruck W., Hortnagl H., Dirnagl U., Bhide P.G., Endres M. Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. Journal of Neuroscience 2001, 21:5045-5053.
12. Kato H., Takahashi A., Itoyama Y. Cell cycle protein expression in proliferating microglia and astrocytes following transient global cerebral ischemia in the rat. Brain Research Bulletin 2003, 60:215-221.
13. Kirwan R.P., Leonard M.O., Murphy M., Clark A.F., O'Brien C.J. Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells. Glia 2005, 52:309-324.
14. Knockaert M., Greengard P., Meijer L. Pharmacological inhibitors of cyclin-dependent kinases. Trends in Pharmacological Sciences 2002, 23:417-425.
15. Leske M.C., Connell A.M., Wu S.Y., Hyman L.G., Schachat A.P. Risk factors for open-angle glaucoma. The Barbados Eye Study. Archives of Ophthalmology 1995, 113:918-924.
16. Liton P.B., Luna C., Challa P., Epstein D.L., Gonzalez P. Genome-wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue. Molecular Vision 2006, 12:774-790.
17. Mahoney W.C., Duksin D. Biological activities of the two major components of tunicamycin. Journal of Biological Chemistry 1979, 254:6572-6576.
18. Masuda Y., Horiguchi H., Dumoulin S.O., Furuta A., Miyauchi S., Nakadomari S., Wandell B.A. Task-dependent V1 responses in human retinitis pigmentosa. Investigative Ophthalmology and Visual Science 2010, 51:5356-5364.
19. Menn B., Bach S., Blevins T.L., Campbell M., Meijer L., Timsit S. Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models. PLoS ONE 2010, 5:e12117.
20. Nho R.S., Hergert P., Kahm J., Jessurun J., Henke C. Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix. American Journal of Pathology 2011, 179:2420-2430.
21. Paul VanVeldhuisen C., Fred Ederer F., Douglas Gaasterland E., Kenneth Sullivan E., Allen Beck, Bruce Prum E., Marshall Cyrlin N. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. American Journal of Ophthalmology 2000, 130:429-440.
22. Quigley H.A. Number of people with glaucoma worldwide. British Journal of Ophthalmology 1996, 80:389-393.
23. Rashidian J., Iyirhiaro G.O., Park D.S. Cell cycle machinery and stroke. Biochimica et Biophysica Acta 2007, 1772:484-493.
24. Schöcklmann H.O., Lang S., Kralewski M., Hartner A., Lüdke A., Sterzel R.B. Distinct structural forms of type I collagen modulate cell cycle regulatory proteins in mesangial cells. Kidney International 2000, 58:1108-1120.
25. Shimazawa M., Inokuchi Y., Ito Y., Murata H., Aihara M., Miura M., Araie M., Hara H. Involvement of ER stress in retinal cell death. Molecular Vision 2007, 13:578-587.
26. Takamoto M., Kaburaki T., Mabuchi A., Araie M., Amano S., Aihara M., Tomidokoro A., Iwase A., Mabuchi F., Kashiwagi K., Shirato S., Yasuda N., Kawashima H., Nakajima F., Numaga J., Kawamura Y., Sasaki T., Tokunaga K. Common variants on chromosome 9p21 are associated with normal tension glaucoma. PLoS ONE 2012, 7:e40107.
27. Timsit S., Menn B. Cerebral ischemia, cell cycle elements and Cdk5. Biotechnology Journal 2007, 2:958-966.
28. Timsit S., Rivera S., Ouaghi P., Guischard F., Tremblay E., Ben-Ari Y., Khrestchatisky M. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death?. European Journal of Neuroscience 1999, 11:263-278.
29. Yasukawa T., Kimura H., Tabata Y., Ogura Y. Biodegradable scleral plugs for vitreoretinal drug delivery. Advanced Drug Delivery Reviews 2001, 52:25-36.
30. Yun A.J., Murphy C.G., Polansky J.R., Newsome D.A., Alvarado J.A. Proteins secreted by human trabecular cells. Glucocorticoid and other effects. Investigative Ophthalmology and Visual Science 1989, 30:2012-2022.